HL7 International is pleased to announce the appointment of three distinguished members to its 2025 Board of Directors.
These new appointees bring a wealth of industry leadership and expertise across data standards, artificial intelligence and clinical innovation, and will serve a two-year term:
- Christopher Longhurst, M.D., M.S., FACMI, chief clinical and innovation officer, University of California, San Diego (UCSD)
Longhurst is a nationally recognized leader in clinical informatics and digital health innovation. As the chief clinical and innovation officer at UCSD, Dr. Longhurst oversees a broad portfolio, including the Offices of the Chief Medical Officer, Quality and Patient Safety, Care Management, Information Services, and the Jacobs Center for Health Innovation, where he leads AI initiatives for personalized medicine and health equity. His leadership in developing cutting-edge health IT aligns with HL7’s mission to empower global health interoperability. - Genevieve Melton-Meaux, M.D., Ph.D., FACMI, director, Center for Learning Health System Sciences, University of Minnesota
Melton-Meaux is an accomplished leader in clinical informatics and AI implementation. With extensive research on learning health systems and digital transformation, she has pioneered strategies that optimize health IT and promote evidence-based care. The current chair of the American Medical Informatics Association (AMIA), her global recognition in AI-driven healthcare innovation underscores HL7’s dedication to advancing intelligent, interoperable solutions.